The basolateral amygdala is critical for generation of anxiety. In addition, exposure to both stress and glucocorticoids induces anxiety. Demonstrated ability of the amygdala to change in response to stress and glucocorticoids could thus be important therapeutic target for anxiety management. Several studies have reported a relationship between anxiety and dendritic arborization of the amygdaloid neurons. In this study we employed a gene therapeutic approach to reduce anxiety and dendritic arborization of the amygdala neurons. Specifically, we overexpressed SK2 potassium channel in the basolateral amygdala using a herpes simplex viral system. Our choice of therapeutic cargo was guided by the indications that activation of the amygdala might underlie anxiety and that SK2 could reduce neuronal activation by exerting inhibitory influence on action potentials. We report that SK2 overexpression reduced anxiety and stress-induced corticosterone secretion at a systemic level. SK2 overexpression also reduced dendritic arborization of the amygdala neurons. Hence, SK2 is a potential gene therapy candidate molecule that can be used against stress-related neuropsychiatric disorders such as anxiety.
Introduction
Fear is an adaptive behavioral response to danger, enabling organisms to evade stimuli that are threatening. Anxiety, on the other hand, is maladaptive expression of fear response. It is usually expressed as generalized and heightened response to stimuli that do not pose or predict danger. [1] [2] [3] [4] The amygdala is an important mediator of fear and anxiety. [5] [6] [7] [8] Among the heterogeneous nuclei of the amygdala, basolateral amygdala (BLA) is especially important, because it serves as an interface between sensory and cognitive realm. 5, 9 It is interesting from a clinical perspective that the triad of amygdala, anxiety and stress is reciprocally interlinked. 1 Stress or stress hormones enhance anxiety. [10] [11] [12] Stress and stress hormones also change structure and function of the BLA, resulting in hypertrophy and increased excitability. [11] [12] [13] [14] [15] BLA, in turn, can enhance secretion of stress hormone, thus potentiating stress response. [16] [17] [18] [19] [20] In addition, a stronger BLA can enhance anxiety. 11, 12, 14 These positive feedbacks might explain the incidence of high stress hormone levels in anxiety disorders. 1, 21, 22 Diminution of these positive feedbacks is of immense clinical significance. We postulate that influencing the BLA plasticity is central to any such approach. Dendritic arborization of principal BLA neurons is tightly linked to anxiety. 11, 13 Dendritic hypertrophy could also affect secretion of stress hormones because of positive feedbacks emanating from BLA on hypothalamic nuclei signaling stress hormone release. 23 Thus, a therapeutic approach targeting dendritic structure of BLA neurons could prove useful in reducing anxiety and stress hormone secretion.
Gene therapy is a powerful means to manipulate the molecular milieu in a targeted population of cells. Within the nervous system, this approach has been primarily used to rescue neurons in response to necrotic neurological insults. [24] [25] [26] As one strategy relevant to the current study, overexpression of the SK2 potassium channel by a herpes simplex viral (HSV) vector protects hippocampal neurons from seizure-induced excitotoxicity. 27 Overexpression of SK2 channels is known to reduce excitatory drive by augmenting the afterhyperpolarization phase of action potential. 28 Thus, in theory, such a reduction in excitatory drive and amygdala activation could affect dendritic architecture and could blunt anxiety and stress hormone secretion. This is the goal of the present study.
Materials and methods

Subjects
Adult male Wistar rats (10 weeks; Charles River Laboratories, Hollister, CA, USA) were used for both morphological and behavioral analyses. Animals were maintained in a 14:10 h light-dark cycle (lights on at 0700 hours) and provided with food and water ad libitum. All procedures were carried out according to NIH guidelines for animal care and were approved by the Stanford University institutional animal care committee (APLAC).
Gene therapy
We employed overexpression of a calcium-activated potassium channel, SK2, through an HSV system. SK2 is responsible for the slow component of afterhyperpolarization of an action potential. Overexpression of SK2 should thus prolong after hyperpolarization and reduce frequency of action potentials. Generation and in vivo overexpression of the SK2 potassium channel using HSV has been previously described in detail. 27 Experimental vector (SK2) consisted of SK2 cDNA under the control of an HSV a4 promoter and b-galactosidase (b-gal) reporter gene under an a22 promoter. Control vector (b-Gal) consisted of b-gal reporter gene alone under an a4 promoter. Both amplicons were packaged into replication-deficient modified HSV vectors and purified with a yield of 1-15 Â 10 6 viral vectors per ml and 10 6 -10 7 helper virus particles per ml. Vectorinduced expression of SK2 in rat brain was originally reported for this vector by Lee et al. 27 in 2003. Similarly, in this report we show the overexpression of SK2 in BLA (Figure 1 ).
Treatments and experimental groups
Control (b-Gal) or experimental (SK2) vectors were infused (2 ml over a 10-min period with a titer of B1 Â 10 6 ) in the BLA (anterior/posterior, À2.3 mm from bregma; medial/lateral, ± 5.1 mm from midline; dorsal/ventral, 7 mm from dura). For behavioral and endocrine studies, a given rat received bilateral infusion of the same vector (b-Gal or SK2). For morphological analysis, b-Gal vector was infused in the left hemisphere and SK2 vector was infused in the right hemisphere, unilaterally.
The viral vector expresses cargo for about 3-4 days after infusion. Most of the parameters (behavior, morphology and endocrine) in this article were measured at a time point 12 days after infusion when the cargo ceased to express (timelines for each experiment given in inset of Figures 2-7 ).
Animals were allowed to recover for 72 h and then randomly divided in three experimental groups. First group was left undisturbed and served as control. Second group was subjected to a single session of 2 h of immobilization stress (1000-1200 hours). Third group was treated with a single injection of corticosterone (CORT, principal glucocorticoid hormone in rats; 10 mg dissolved in 1 ml peanut oil per kg body weight; subcutaneously). These treatments are known to produce sustained elevations of circulating CORT concentrations in the range seen during major stressors. 11, 29, 30 Separate sets of animals were employed for behavioral, endocrine and morphological measurements to A subset of animals was tested sequentially for performance in the EPM and in the circular open arena. A second subset was used to measure performance in rectangular open field. All behavioral tests were conducted in same room.
To address specificity of BLA function through gene therapeutic intervention, we carried out additional infusion in a nearby brain region, the piriform cortex (PC: anterior/posterior, À2.3 mm from bregma; medial/lateral, ± 6.1 mm from midline; dorsal/ventral, 5.2 mm from dura), and tested the animals (n = 6) for anxiety on EPM.
Plasma corticosterone concentration
Concentration of circulating plasma CORT was quantified 3 (basal and stress induced) and 12 days (basal) after the infusion. Same animals were not always used for blood collection at all three points. A smaller subset of animals was employed for collecting stressinduced samples. A total of 4-6 animals were used for different time points of CORT collection.
Stress-induced samples were collected by immobilizing animals for 30 min and collecting blood immediately thereafter. For blood collection, animals were gently held inside a dark towel and up to 100 ml blood was collected in heparinized tubes through a tail nick. This method is known to induce minimal stress during repeated blood collection. 32 The tubes were kept on ice and were subsequently centrifuged to collect the plasma (5415C, Eppendorf, Westbury, NY, USA; 10 000 r.p.m. for 10 min). CORT titers in plasma (diluted 11 times) were assessed using a competitive enzyme immunoassay kit (Assay Design, Minneapolis, MN, USA). This assay typically results in a sensitivity value of 27 pg/ml (concentration of CORT two standard deviation away from zero on standard curve). This assay method has low crossreactivity to testosterone ( < 0.15%).
Morphological studies and analysis
Morphological analysis was conducted 12 days after the infusion. Animals were decapitated under deep fluorothane anesthesia. Freshly dissected brain tissues containing the amygdala were processed for staining individual neurons using rapid Golgi method. 15, 16 Golgi-stained BLA tissue was sectioned (120-mm thick), mounted with coverslip and used for morphological analysis. Camera Lucida tracings (500 Â ) were obtained (Nikon, Melville, NY, USA) from selected neurons and were then scanned (8-bit grayscale TIFF images with 600 d.p.i. resolution, Canon MultiPass MP360) along with a calibrated scale for subsequent computerized image analysis. Custom-designed macros embedded in 'Scion Image' software (http://www.scioncorp.com/) were used for morphometric analysis of digitized images. Using the center of the soma as the reference point, we measured dendritic length and branch points as a function of radial distance from the soma by adding up all values in each successive concentric segment (Sholl's analysis). An average of 40-50 neurons from 
Statistical analysis
Values are reported as mean±s.e.m., and percentage changes are calculated with respect to corresponding control values. The differences between naive animals infused with SK2 and b-gal were analyzed using Student's t-test. Effects of infusion on secretion of endogenous CORT were assessed using nonparametric Mann-Whitney U-test, because this data set was not normally distributed. Two-way analysis of variance (ANOVA) was conducted to measure effects of treatment (control, stress or CORT treatment) and infusion (b-Gal or SK2) on behavioral and morphological end points. Orthogonal planned comparisons were used to compare effects of infusion (b-Gal versus SK2, Student's t-test). No mean was compared more than once during the planned comparison. We further investigated the effects of SK2 on anxiety by employing a circular open arena. SK2-treated rats spent more time away from the wall (Figure 3a ; center defined as at least 18.75 cm away from wall; 253% increase; P < 0.05, n = 12). This was not due to a generic increase in locomotion, because SK2 and control vector rats did not differ in the total distance traveled (Figure 3b ; P > 0.4, n = 12). A different set of animals was also tested in a smaller rectangular open field. SK2-treated animals made more number of crossings into the center of the arena (Figure 3c ; P < 0.05, n = 5-6). In summary, animals treated with SK2 exhibited enhanced exploration of anxiogenic compartments in EPM and open fields, without affecting locomotion itself. Thus, we conclude that SK2 infusion in BLA reduced anxiety.
Results
SK2 overexpression in BLA reduced anxiety
SK2 overexpression in BLA reduced stress-induced CORT levels SK2 overexpression did not affect baseline plasma CORT levels 3 days after infusion of vector (Figure 4a ; P > 0.13). Immobilization stress (30 min) increased circulating CORT. Magnitude of stress-induced plasma CORT was significantly reduced in animals overexpressing SK2 (Figure 4b ; 74% reduction; P < 0.005, Mann-Whitney test). No differences in baseline CORT were found at 12 days after treatment (Figure 4c ; P > 0.3), a time-point when infused vectors had ceased to express cargo. A total of 4-6 animals per group were used for CORT measurements. 
SK2 overexpression in BLA reduced dendritic length of neurons
We studied the effects of SK2 on dendritic arborization of BLA principal neurons by infusing SK2 in one hemispheric BLA and b-Gal in the contralateral BLA. Morphological measures were performed 12 days after infusion on 40-50 neurons from 4-5 animals. Neurons from SK2-infused BLA showed reduced dendritic length (Figure 5a ; 14% reduction; P < 0.05), with no differences in the number of branch points (Figure 5b ; P > 0.4). Figure 5c depicts representative camera Lucida drawings obtained from neurons treated with either SK2 (lower) or b-Gal (upper). A detailed segmental analysis revealed that SK2 overexpression reduced dendritic length along distal segments of BLA neuron, between 160 and 200 mm away from the cell soma (Figure 5d ).
SK2 reduced dendritic length in stressed and CORTtreated animals
Previous studies have reported that stress and stress hormones cause BLA dendritic expansion. 11, 13 In that context, we studied the effects of SK2 infusion on dendritic arborization in animals treated with either acute stress or acute stress hormone injection (40-50 neurons from 5-6 animals). Morphological parameters were collected 10 days after the stress or stress hormone treatment (12 days after infusion). A twoway ANOVA revealed a significant main effect of SK2 infusion (Figure 6a ; P = 0.001; F 1,277 = 15.2, SK2 < b-Gal) and treatment (P < 0.001; F 2,277 = 37.5, stress > CORT > naive) on dendritic length. Interaction between treatment and infusion was not significant (F 2,277 = 0.51; P > 0.5). Planned comparisons revealed that overexpression of SK2 significantly reduced the effects of stress and CORT on dendritic length (P < 0.05). Such dendritic retraction is similar to the effects of SK2 in naive unstressed animals ( Figure 5 ). However, segmental analysis showed that SK2 overexpression in stressed animals reduced dendritic length more proximally (110-180 mm away from cell body; Figure 6b ), in contrast to distal retraction observed in naive animals (Figure 5d ).
SK2 did not affect anxiety in stressed and CORTtreated animals As described earlier (Figures 2 and 3) , SK2 infusion in naive animals reduced anxiety. We tested if SK2 also reduced anxiety in animals treated with stress or stress hormone (8-10 animals per group). Two-way ANOVA revealed significant main effect of SK2 infusion on percentage open-arm entries made in the EPM (F 1,47 = 5.5, SK2 > b-Gal; P < 0.05). Main effect of treatment and interaction failed to reach statistical significance (F 2,277 < 0.5, P > 0.5).
Although SK2-treated animals showed a trend of increase in open-arm exploration in stress and CORT-treated animals, planned comparison between the groups failed to reach statistical significance (Figure 7a ; P > 0.2). A similar trend was observed in open-field exploration in case of stressed animals (Figure 6b ; P > 0.08), while CORT-treated animals were not different than controls (Figure 7b ; P > 0.84).
Discussion
Anxiety disorders are among the most debilitating psychiatric diseases, characterized by a maladaptive fear response. The amygdala is critical for both fear and anxiety. Thus modulation of amygdaloid function will be relevant to management of anxiety disorders. Previously, gene therapeutic approaches have been used to manipulate the amygdala and amygdaladependent behaviors. For example, virally mediated overexpression of enkephlin in the amygdala reduces pain responsiveness and augments the ability of benzodiazepines to reduce anxiety. 33, 34 Virally mediated blockage of synaptic incorporation of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors also blocks associative learning. 35 In this study we demonstrate that overexpression of a potassium channel, SK2, can alter amygdala-dependent behavior, structure and function. Moreover, these effects are present long after the viral vector has ceased to express its cargo. To the best of our knowledge, the present report is the first gene therapeutic approach to target stress hormone secretion and long-term anxiety.
Pathological anxiety is thought to reflect a maladaptive state characterized by exaggerated fear mismatched with actual environmental stimuli. There has been growing interest in the importance of the amygdala in anxiety, because the amygdala is known to be central for fear responses. [5] [6] [7] [8] [9] Manipulations that enhance anxiety also enhance dendritic arborization, number of spines, gross volume and synaptic transmission in the amygdala. 11, 12, 14, 15 N-methyl-D-aspartate (NMDA) receptor antagonists in the amygdala blunt anxiety, 36 whereas reduction in inhibitory tone by g-aminobutyric acid (GABA) receptor blockade facilitates anxiety. 37 These observations in rats are supported by parallel studies in primates and humans. For example, lesion studies in rhesus monkeys suggest that bilateral destruction of the central amygdala reduces fear and anxiety-related behaviors. 38 In humans, amygdala activation is a reliable predictor of anxiety. [39] [40] [41] [42] [43] Activation of the amygdala is positively correlated with severity of social anxiety symptoms. 44 Moreover, amygdala volume is increased in generalized anxiety disorders. 45, 46 These observations suggest that the amygdala is an important target for therapeutic interventions against anxiety.
In this study, we focused on virally mediated overexpression of SK2 in the BLA. As noted, abnormal activation of BLA is thought to be relevant to anxiety disorders. 11, 12, 14, 36 We have previously observed that SK2 overexpression can protect hippocampal neurons from excitotoxicity, both in vitro and in vivo. 27 Here we report that SK2 overexpression reduces anxiety, causes dendritic retraction in BLA and reduces stress-induced CORT secretion SK2 reduces anxiety, CORT and BLA hypertrophy R Mitra et al peripherally. These effects are not related to an acute decrease in activity of BLA neurons. This is because the HSV amplicon vectors only express their cargo for 3-5 days and in this study behavioral and anatomical effects were observed long after the vector had ceased to express SK2. Hence, a long-term plastic change rather than acute suppression of neuronal activity is more likely to be involved in bringing about the effects. As is typical with HSV vectors, only a small percentage of neurons were infected. This was nonetheless sufficient to drive long-term changes. This is in agreement with previous reports where infection of only a small percentage of neurons can potentially alter function. 35, 47 Finally, although HSV is primarily a neurotropic virus, it still does infect some glia. Thus, a function of glia in indirectly modulating neuronal and functional change cannot be ruled out.
Various studies have investigated the relationship between dendritic changes in the BLA and behavioral changes. Of particular interest to this report, stress and stress hormones cause dendritic expansion of BLA neurons and such dendritic expansion is thought to be important for ensuing enhancement in anxiety. 11, 14 This is in agreement with reports that link dendritic changes in hippocampus to behavioral changes in memory. 48 Changes in dendritic arborization can directly affect passive electrotonic property of neurons. 49, 50 Coupled with passive changes, there is possibility that active ion channels could also get purged during dendritic retraction. Because of previous reports linking dendritic expansion in BLA to anxiety and because SK2-induced dendritic retraction could affect electrical property of neurons, the effects of SK2 on anxiety might have arisen from SK2-induced dendritic retraction.
Similar to its effects on naive animals, SK2 overexpression also reduced dendritic length in animals exposed to either acute stress or acute treatment of CORT. Both of these treatments cause dendritic hypertrophy. 11, 14 Whereas we did see a trend of reduced anxiety in SK2-treated animals exposed to stress or CORT, stress and CORT themselves did not have much effect on anxiety. One possibility is that anxiety in our animals was already very high, perhaps due to the stress of the bilateral stereotaxic surgery. Further enhancement of anxiety by stress or CORT was not possible within the dynamic range of behavioral tests we employed.
As noted, the mechanisms underlying dendritic expansion and retraction in the BLA are poorly understood. One possibility is that the activity of neurons regulates level of cytosolic Ca þ 2 and that in turn influences cytoarchitectural reorganization. For example, activation of Ca þ 2 permeable NMDA channels in Xenopus tectal neurons promotes dendritic outgrowth. 51 In rat motor neurons, in vivo delivery of DNA coding for GluR1, a subunit of glutamatergic AMPA channel, results in enhanced branching of the neurons. 52 It is possible that by virtue of reduced neuronal activity, SK2 reduces the level of cytosolic Ca þ 2 and thus influences cytoarchitecture promoting dendritic retraction.
We also observed that overexpression of SK2 attenuated secretion of CORT in response to stress. Our results show that stress-induced levels of CORT in b-gal animals is comparable to stress-induced levels reported in animals left untreated with any vector. [53] [54] [55] [56] In contrast, SK2 infused animals have lower levels of CORT compared to widely known levels of stress-induced CORT. Interestingly, hypersecretion of CORT is known to occur in human anxiety as well as in rodent models of anxiety. 1, 21, 22 In rats, treatment with anxiety-reducing drugs (such as chlordiazepoxide or diazepam) reduces stress-induced CORT secretion. 57 Similarly, an anxiolytic acetylcholine receptor antagonist, mecamylamine, reduces stress-induced CORT secretion in rats. 58 Our findings are in agreement with these reports, suggesting that anxiolysis is related to decrease in circulating CORT. A possible mechanistic explanation for this relationship is the fact that amygdala activity can stimulate CORT secretion, and thus mediate the activating effects of many stressors on the adrenocortical axis. 19, 23 In summary, we show that transient overexpression of SK2 in the BLA can protect against anxiety. It can also reduce stress-induced peripheral CORT secretion and dendritic arbors of the BLA neurons, both of which have been shown to be directly related to anxiety. Hence, this approach is of heuristic value in understanding the neurobiology of anxiety, and may also pave the way for eventual therapeutic interventions.
